Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. (Q51425178)

5 April 2018

title

Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. (English)

1 reference

5 April 2018

retinopathy of prematurity

main subject

1 reference

2

1 reference

5 April 2018

Monica Fumagalli

11

1 reference

5 April 2018

Massimo Agosti

Massimo Agosti

23

0 references

Luca Filippi

Luca Filippi

1

0 references

Giancarlo la Marca

Giancarlo la Marca

12

0 references

Gianpaolo Donzelli

8

Gianpaolo Donzelli

1 reference

5 April 2018

Paola Bagnoli

3

1 reference

5 April 2018

Massimo Dal Monte

4

1 reference

5 April 2018

Patrizio Fiorini

5

1 reference

5 April 2018

Elettra Berti

6

1 reference

5 April 2018

Letizia Padrini

7

1 reference

5 April 2018

Gabriella Araimo

9

1 reference

5 April 2018

Gloria Cristofori

10

1 reference

5 April 2018

Maria Luisa Della Bona

13

1 reference

5 April 2018

Roberta Pasqualetti

14

1 reference

5 April 2018

Pina Fortunato

15

1 reference

5 April 2018

Silvia Osnaghi

16

1 reference

5 April 2018

Barbara Tomasini

17

1 reference

5 April 2018

Maurizio Vanni

18

1 reference

5 April 2018

Anna Maria Calvani

19

1 reference

5 April 2018

Silvano Milani

20

1 reference

5 April 2018

Ivan Cortinovis

21

1 reference

5 April 2018

Alessandra Pugi

22

1 reference

5 April 2018

Fabio Mosca

24

1 reference

5 April 2018

language of work or name

English

0 references

publication date

4 November 2016

1 reference

5 April 2018

published in

Pediatric Research

1 reference

5 April 2018

volume

81

1 reference

5 April 2018

page(s)

307-314

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1038/pr.2016.230

exact match

0 references

cites work

Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Oxygen-induced retinopathy: a model for vascular pathology in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Protective effects of β1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Medications used to manage supraventricular tachycardia in the infant a North American survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Congenital thyrotoxicosis in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Treatment of systemic hypertension in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Propranolol: a new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

The International Classification of Retinopathy of Prematurity revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Propranolol concentrations after oral administration in term and preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Propranolol for severe hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Infantile hemangiomas and retinopathy of prematurity: possible association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Topically applied pilocarpine. Human pupillary response as a function of drop size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Pharmacokinetics of topically applied ophthalmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Causes of blindness and severe visual impairment in children in Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Retinopathy of prematurity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Oral propranolol in early stages of retinopathy of prematurity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Pharmacokinetics and local safety profile of propranolol eye drops in rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Screening examination of premature infants for retinopathy of prematurity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

β-Blocking and racial variation in the severity of retinopathy of prematurity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.230

Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27814346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oxygen-induced retinopathy in the mouse

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27814346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blood pressure measurements in the newborn

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27814346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PR.2016.230

1 reference

5 April 2018

PubMed ID

27814346

1 reference

5 April 2018